Company

Pikermi
Pikermi

The Pikermi facility occupies a land area of 15,000 m² with a total built surface of 16,000 m².

Keratea
Keratea

Plants featuring: High capacity & flexibility in the management of pharmaceutical forms. Technological superiority and differentiation. Potential to access new markets worldwide.

Personal Data Protection Policy In Relation To Pharmacovigilance
Personal Data Protection Policy In Relation To Pharmacovigilance

Privacy Policy
Privacy Policy

Medical Information Enquiries Privacy Notice
Medical Information Enquiries Privacy Notice

Privacy Notice for Partners and Suppliers
Privacy Notice for Partners and Suppliers

Notice regarding the Processing of Personal Data of Employees, Candidates Employees and Former Employees, in accordance with current Greek and European Union legislation
Notice regarding the Processing of Personal Data of Employees, Candidates Employees and Former Employees, in accordance with current Greek and European Union legislation

Financial Statements 2021
Financial Statements 2021

Financial Statements 2020
Financial Statements 2020

Financial Statements 2019
Financial Statements 2019

Financial Statements 2018
Financial Statements 2018

Personal Data
Personal Data

Financial Statements 2017
Financial Statements 2017

At a glance
At a glance

ELPEN: A Family Business with a Global Footprint

Terms of Use
Terms of Use

Our people
Our people

60+ Years of Innovation
60+ Years of Innovation

For more than 60 years, the pharmaceutical company ELPEN has been developing and producing high quality branded and generic medicines for the Greek and International markets.

Vision, Mission, Values
Vision, Mission, Values

We create effective treatments to improve and extend the lives of our fellow human beings.

ELPEN - The leading greek pharmaceutical company
Search